We are a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging our extensive expertise in E3 ligases together with our proprietary DNA-encoded libraries, we have built DELigase, an integrated discovery platform to identify […]

  We are a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. Through our in-depth understanding of the biological pathways involved in mineralization, we are pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established […]

  Vertex delivers comprehensive tax solutions that enable global businesses to transact, comply and grow with confidence. Companies with complex tax operations rely on Vertex to automate their end-to-end indirect tax processes. Indirect tax is the largest corporate tax category, encompassing sales tax, seller’s use tax, consumer use tax and VAT, among others. Indirect tax […]

  While we may pursue an initial business combination with a company in any industry, sector or geographic location, we intend to focus our search on opportunities where we believe we can capitalize on the experience and expertise of our management team to identify, acquire and potentially operate a business in what we call the […]

  We will seek to acquire businesses that service the real estate industry. Our target companies will range from real estate service companies to property technology, or “PropTech,” companies. Real estate service companies include property management companies, real estate service providers, mortgage brokerage companies, real estate investments sales companies, title agencies and any other company […]

(Note: This is an offering of 2.55 million units, according to an SEC filing on Aug. 24, 2020, in which the IPO was changed to a unit offering from one of common shares. Each unit consists of one of our ordinary shares and one warrant to purchase one ordinary share. We have applied to list our […]

  We are a newly formed blank check company that intends to initially focus our search for a target business in the healthcare or healthcare-related industries in the United States and other developed countries. We intend to focus our investment effort broadly across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics, and animal […]

  We intend to focus our efforts on identifying a prospective target business with either all or a substantial portion of its activities in North America or Europe. We expect to focus on travel-related and travel-adjacent businesses that have attractive growth-oriented characteristics and strong underlying demand drivers which include business services and travel infrastructure platforms such as visa […]

  We are the standard in Apple Enterprise Management, and our cloud software platform is the only vertically-focused Apple infrastructure and security platform of scale in the world. We help organizations, including businesses, hospitals, schools and government agencies, connect, manage and protect Apple products, apps and corporate resources in the cloud without ever having to […]

  Since our inception in 2012, our mission has been to help clients and communities meet their environmental goals and needs. Today, we have emerged as one of the fastest growing companies in a highly fragmented and growing $1.25 trillion global environmental industry. We service complex, recurring and often non-discretionary environmental needs of our diverse clients across […]